MARKET

PODD

PODD

Insulet Corp
NASDAQ
149.81
+3.30
+2.25%
After Hours: 150.00 +0.19 +0.13% 17:36 11/09 EST
OPEN
146.85
PREV CLOSE
146.51
HIGH
150.52
LOW
145.41
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
126.40
MARKET CAP
10.39B
P/E (TTM)
24.41
1D
5D
1M
3M
1Y
5Y
1D
Insulet price target raised to $160 from $153 at Truist
TipRanks · 13h ago
Insulet Price Target Raised to $160.00/Share From $153.00 by Truist Securities
Dow Jones · 13h ago
Truist Securities Reiterates Hold on Insulet, Raises Price Target to $160
Benzinga · 13h ago
Insulet launches ‘Give Yourself the Freedom to’ campaign
TipRanks · 15h ago
Weekly Report: what happened at PODD last week (1102-1106)?
Weekly Report · 18h ago
For World Diabetes Day, Insulet Launches “Give Yourself the Freedom to” Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being
Barchart · 22h ago
Insulet Corp. Stock Sheds 6.2%, Underperforms Peers
Dow Jones · 3d ago
DexCom Inc. Stock Sheds 6.0%, Underperforms Market
Dow Jones · 3d ago
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.